Table 2.
Distribution of study participants by blood pressure variables (n = 112)
| Blood pressure variable | n (%) |
|---|---|
| Duration since diagnosed with blood pressure (years), Median (IQR) | 4.5 (2–10) |
| Routine care, n (%) | |
| Yes | 45 (40.2) |
| Frequency of review, n (%) | |
| Not reviewed | 64 (57.1) |
| Monthly | 32 (28.6) |
| Every 2 months | 6 (5.4) |
| Every 3 months | 10 (8.9) |
| Current treatment for hypertension, n (%) | |
| Yes | 53 (47.3) |
| Drugs participant uses for blood pressure, n (%) | |
| Calcium channel blockers | 43 (39.1) |
| Diuretics | 14 (12.7) |
| Β-blockers | 15 (13.6) |
| ACEIs/ARBs | 37 (33.6) |
| Alpha–adrenergic agonist (methyldopa) | 1 (1) |
| Drug therapy, n (%) | |
| Mono-therapy | 16 (28.1) |
| Duo-therapy | 33 (57.9) |
| Multi-therapy | 8 (14.0) |
| Lipid lowering therapy, n (%) | |
| Yes | 3 (2.6) |
| Herbal medication, n (%) | |
| Yes | 37 (33.0) |
| Family history of hypertension, n (%) | |
| Yes | 59 (52.7) |
| Challenges experienced on drugs, n (%) | |
| Cost | 47 (42.3) |
| Access | 9 (8.1) |
| Side effects | 4 (3.6) |
| Pill load | 3 (2.7) |
| None | 45 (40.5) |
| Previous diagnosis of diabetes mellitus, n (%) | |
| Yes | 24 (21.4) |
| Currently on medication for diabetes, n (%) | |
| Yes | 21 (87.5) |
| Level of control for sugar, n (%) | |
| Good | 20 (95.2) |
| Poor | 1 (4.8) |